FDA-approved for the treatment of non-infectious degenenerative and/or traumatic joint dysfunction
Requires a veterinarian's prescription
Active ingredient: Polysulfated Glycosaminoglycan (PSGAG) Form: Intramuscular (i.m.) injection
Adequan® i.m. (polysulfated glycosaminoglycan) is the only FDA-approved treatment proven to relieve symptoms of non-infectious degenerative osteoarthritis, to stimulate cartilage repair and reverse the joint disease process. There is no generic version of Adequan® i.m. Studies have not been conducted to establish safety in breeding horses. WARNING: Do not use in horses intended for human consumption. Not for use in humans. Keep this and all medications out of the reach of children. Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian. See product package insert for full prescribing information by visiting www.adequan.com. Adequan® i.m. is available in 5 mL vials, packaged individually or in boxes of 7, or as a 50 mL multi-dose vial (all vials contain 500 mg of PSGAG per 5 mL).
The recommended dose of Adequan® i.m. in horses is 500 mg every 4 days for 28 days intramuscularly. The injection site must be thoroughly cleansed prior to injection. Do not mix Adequan® i.m. with other drugs or solvents.
Brittany and Nate Ever since I was the girl with 1,000 breyer horses and the raggity braid in her hair, I was always obsessed. In second grade I moved into a town with a barn right down the street, which is when I started taking lessons...
Horse of the Month: Carmella Horse of the Month: Carmella Breed: Miniature Horse PATH Intl. Accredited Center: Colorado Therapeutic Riding Center Location: Longmont, CO Carmella is the Colorado Therapeutic Riding Center’s (CTRC) miniature horse and part of our Mini Troopers program. CTRC’s Mini Troopers program